Hotline:
+ 49 (0) 2204 2918806

Market studies for category Pharmaceuticals

Items 1 to 10 of 7813 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 782
  1. Net price*
    Year
  2. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Malignant Glioma - Pipeline Review, H2 2013

    Global Markets Direct
    64 pages
    Global Markets Direct’s, 'Malignant Glioma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Malignant Glioma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key pla
    Englisch | Zukunftsanalyse | SKU: 386263
  3. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Oncodesign SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    27 pages
    Oncodesign is a France-based biotechnology company. It provides drug discovery and pharmacological evaluation services in the field of cancer. The company specializes in the preclinical assessment of anti-cancer therapies. Oncodesign’s business activities include the provision of preclinical evaluation services comprising a range of pro
    Englisch | Zukunftsanalyse | SKU: 331018
  4. $1,500.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Grifols, S.A. - Product Pipeline Review - 2014

    Global Markets Direct
    46 pages
    Global Markets Direct’s, ‘Grifols, S.A. - Product Pipeline Review - 2014’, provides an overview of the Grifols, S.A.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Grifols, S.A.’s, complete with comparative analysis at various st
    Englisch | Zukunftsanalyse | SKU: 394093
  5. $3,495.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Saphris (Schizophrenia) - Forecast and Market Analysis to 2022

    GlobalData
    44 pages
    Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning and cognitive deficits. WHO experts have
    Englisch | Zukunftsanalyse | SKU: 402861
  6. $2,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    T-Cell Lymphomas – Pipeline Review, H2 2012

    Global Markets Direct
    320 pages
    Introduction Global Markets Direct’s, 'T-Cell Lymphomas - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for T-Cell Lymphomas, complete with latest updates, and special features on late-stage and discontinued projects. It also re
    Englisch | Pipeline Review | SKU: 317619
  7. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    One Way Liver Genomics, S.L. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    20 pages
    OWL Genomics, S.L. (OWL Genomics) is a biotechnology company. The company offers products and services in the field of metabolomics. It provides owl liver, an in vitro blood based diagnostic for Steatosis and NASH based on metabolic procedures. The company offers services, such as screening services, biomarker search and identification, c
    Englisch | Zukunftsanalyse | SKU: 987673052
  8. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Select Medical Holdings Corporation (SEM) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Pages
    Select Medical Holdings Corporation (SMHC) is a healthcare service provider. The company owns and manages specialty hospitals, inpatient and outpatient rehabilitation clinics. It provides services such as specialty hospitals: cardiac services, infectious disease treatment, low back rehabilitation, work injury prevention and management, at
    Englisch | Zukunftsanalyse | SKU: 149965
  9. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Pompe Disease - Pipeline Review, H2 2014

    Global Markets Direct
    62 pages
    Global Markets Direct’s, ‘Pompe Disease - Pipeline Review, H2 2014’, provides an overview of the Pompe Disease’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Pompe Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechani
    Englisch | Zukunftsanalyse | SKU: 987671766
  10. $2,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Thalassemia – Pipeline Review, H2 2012

    Global Markets Direct
    76 pages
    Introduction Global Markets Direct’s, 'Thalassemia - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Thalassemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key
    Englisch | Report | SKU: 318259
  11. $2,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Hereditary Angioedema (HAE) - Pipeline Review, H1 2015

    Global Markets Direct
    78 pages
    Global Markets Direct’s, ‘Hereditary Angioedema (HAE) - Pipeline Review, H1 2015’, provides an overview of the Hereditary Angioedema (HAE)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hereditary Angioedema (HAE), complete with comparative analysis at various stages, thera
    Englisch | Zukunftsanalyse | SKU: 987688352

Items 1 to 10 of 7813 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 782